The invention provides compounds of Formula I: ##STR00001## wherein Azabicyclo is ##STR00002## where the variables have the definitions discussed herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat a disease or condition in which .alpha.7 is known to be involved.